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EXECUTIVE SUMMARY
Lung cancer has the lowest survival rate of all cancers in adults, with only 13% of affected
individuals in Australia surviving for five or more years following a diagnosis. It is generally
recognised that early diagnosis of lung cancer could be an important factor in improving both
the survival rate and patients’ quality of life. One way to facilitate the early diagnosis of lung
cancer is to improve people’s awareness of the signs and symptoms of the disease (e.g. a
persistent cough, coughing up blood, fatigue, and weight loss) and encourage them to attend
their general practitioner (GP) for investigation of potential symptoms.
The objective of this rapid review was to identify and examine lung cancer ‘signs and symptoms’
interventions which have been developed in Australia and OECD countries with similar
healthcare settings (i.e. New Zealand (NZ), Canada, and the United Kingdom (UK)). This involved
assessing the effectiveness of these interventions on influencing knowledge, attitudes, beliefs,
and help seeking behaviours (e.g. GP visits) in the general community and at-risk groups (e.g.
smokers, individuals from a low socio-economic background, culturally and linguistically diverse
(CALD) communities. In addition, the effectiveness of interventions designed to influence the
knowledge, attitudes, beliefs, and behaviours of health professionals was also examined.
A review of the academic and grey literature resulted in the identification of eight lung cancer
‘signs and symptoms’ interventions: ‘I’ll tackle it soon’ (UK), ‘3 Week Cough’ (UK), ‘Be Clear on
Cancer’ (UK), ‘Cough, cough, cough’ (NZ), ‘The Sooner the Better’ (NZ), ‘The Australian Lung
Foundation’ (various programs; Australia), ‘Find Cancer Early’ (Australia), and ‘Detect Cancer
Early’ (UK). The primary aim of all of these interventions was to raise awareness of the signs and
symptoms of lung cancer, and increase help seeking behaviour (e.g. seeking help from a GP or
other healthcare professional). The interventions typically targeted a single sign and symptom
(i.e. a persistent cough lasting for three weeks or more). However, the ‘Be Clear on Cancer’
intervention publicised additional lung cancer signs and symptoms such as coughing up blood,
breathlessness, fatigue, chest/shoulder pain.
The evidence for the effectiveness of these interventions was very limited. For example, only two
of the eight interventions had any evaluation data (‘I’ll tackle it soon’, and ‘3 Week Cough’).
These data did indicate that the interventions had positive effects. For example, ‘I’ll tackle it
soon’ led to a significant increases in GP visits for lung cancer, along with a 20% increase in chest
x-rays and a 27% increase in lung cancer diagnoses. The ‘3 Week Cough’ intervention similarly led
to a 23% increase in GP attendances for patients with a cough or other symptoms of lung
cancer. Unfortunately, in addition to being limited in quantity, the quality of the evidence was
assessed as being low.
There was also no indication of whether these ‘signs and symptoms’ interventions led to changes
in knowledge, attitudes, or beliefs. There were no data examining the effectiveness of these
interventions on relevant at-risk populations such as individuals from lower socio-economic
groups, indigenous groups, or CALD communities. Furthermore, although some of the
interventions indicated that they included a component targeted towards health professionals,
there are no published data examining the effects of these health professional components. As a
consequence, it is not possible to determine whether lung cancer ‘signs and symptoms’
interventions are effective in influencing health professionals’ knowledge, attitudes, beliefs, and
relevant behaviours.
The very limited data for lung cancer ‘signs and symptoms’ interventions led to an expansion of
the review to also encompass ‘signs and symptoms’ interventions for other relevant cancers such
as breast cancer, prostate cancer, and colorectal cancer (a preliminary search was also
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conducted for chronic obstructive pulmonary disease interventions, but recent published data
were not available). This resulted in the identification of 11 relevant interventions for which
evaluation data were available: five of these were for breast cancer, four for colorectal cancer,
and two for prostate cancer.
These interventions did focus on increasing awareness of cancer signs and symptoms, but had a
range of other goals such as increasing visits to GPs and screening, and increasing detection
rates of cancer. The evaluation data were considerably more detailed for these cancers relative
to lung cancer. Several of the interventions led to significant improvements in knowledge and
awareness of cancer signs and symptoms. For example, the ‘Be Clear on Cancer’ colorectal
cancer campaign led to approximately 50% increase in awareness of symptoms (e.g. ‘blood in
poo’). The ‘Learn, Share and Live’ intervention led to an increase in the percentage of women
who indicated that they had recently been screened for breast cancer (from 40% to 68%).
Furthermore, the ‘Screen for Life’ intervention was associated with a 19.3% increase in screening
rates for colorectal cancer between 2002 and 2008. There was also evidence of increases in visits
to healthcare professionals. For example, ‘Be Clear on Cancer’ led to a 48% increase in GP visits
for colorectal cancer signs and symptoms.
Unfortunately, the quality of the evaluation data was generally low. Therefore, although these
interventions generally had positive effects on the outcome measures these need to be
interpreted with caution. In particular, there is a need for more rigorous research designs (e.g.
randomised control trials (RCTs), or well-designed observational studies that yield extremely large
and consistent estimates of the magnitude of an intervention effect) to better determine the
effectiveness of these interventions. Furthermore, as per the lung cancer ‘signs and symptoms’
interventions, evaluation data did not identify factors that influenced the effectiveness of these
interventions, or whether effectiveness varied according to socio-economic or CALD status.
The results of this rapid review indicate that very few ‘signs and symptoms’ interventions for lung
cancer have been developed and trialled in Australia, NZ, the UK and Canada. Based on the
available data it is concluded that:
Question 1a. ‘Signs and symptoms’ interventions may be effective influencing
knowledge, attitudes, beliefs and help seeking behaviours such as visits to a GP or taking
up screening. However the evidence base is limited, especially in relation to lung cancer,
with some limited evidence from other cancer interventions suggesting a positive effect.
Question 1b. There is very limited published evidence of the effectiveness of lung cancer
‘signs and symptoms’ interventions targeted towards at risk population groups.
Question 2. There is insufficient evidence to make any conclusions regarding
interventions targeted towards health professionals
Based on the available evidence, the following recommendations are made for developing lung
cancer ‘signs and symptoms’ interventions in NSW.

6

1.

Interventions should be based on rigorous formative research with target population
groups and stakeholders to generate understanding and useful insights regarding
knowledge, attitudes, and behaviours, and explore issues, influences and barriers to
increasing awareness and changing behaviour

2.

Segmentation of target populations – beyond simple demographic based approaches,
but using formative research to identify psychographic audience segments can facilitate
targeted and tailored intervention messages

3.

Capacity building and training with relevant stakeholders such as healthcare
professionals can be helpful to alleviate concerns over resources and build support for
intervention aims and objectives

The Sax Institute
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4.

Future interventions should use relevant theories to help identify applicable factors
influencing behaviour, and to develop behaviour change strategies

5.

Evaluation research models which include process, and cost effectiveness, as well as
outcome evaluation data, should be built in at the start of future interventions as existing
interventions do not report these data

6.

A social marketing framework can provide a comprehensive and strategic structure for
incorporating the aforementioned recommendations. Social marketing has been shown
to be an effective approach for colorectal cancer (Cancer Research UK 2007), and
more widely for population health behaviour change interventions (Stead et al. 2007). In
addition, utilising an internal social marketing approach – the application of internal
marketing for the achievement of social rather than commercial objectives (Smith 2011),
to engage relevant stakeholders in the healthcare sector can overcome barriers such as
concerns over capacity and support in the system; and issues over procedures and
protocols.

The Sax Institute
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1 Introduction
Lung cancer is the fourth most commonly diagnosed invasive cancer in Australian adults
(excluding basal cell carcinoma and squamous cell carcinoma), accounting for approximately
8% of all cancers (Australian Institute of Health & Welfare (AIHW) 2010). Lung cancer refers to any
carcinoma that originates in the lungs (e.g. trachea, bronchi, bronchioles, & alveoli) and can be
categorised according to two main types:
1.

Small cell carcinoma. This is the most aggressive form of lung cancer and spreads very
rapidly during the early course of the disease. This means that by the time it is diagnosed,
surgery (i.e. removal of the tumour) is often not an effective form of treatment, and the
only options are radiotherapy or chemotherapy

2.

Non-small cell carcinoma. This is a less aggressive form of lung cancer that grows and
spreads more slowly. Because the tumour tends to be confined to parts of the lung for a
longer period of time, surgery is a more effective treatment option relative to small cell
carcinoma.

Lung cancer is a major public health issue as it has a higher mortality rate in both males and
females than any other cancer (AIHW 2010). For example, only 13% of diagnosed individuals
survive five years after diagnosis, which is considerably lower than the survival rates for breast
cancer, prostate cancer, and bowel cancer (AIHW 2010). Lung cancer is more common in males
than females; however, the magnitude of this difference has changed considerably over the
past 30 years. In 1982, males were 4.7 times more likely to be diagnosed with lung cancer. By
2007, this had fallen to 1.8 times more likely (AIHW 2010). This reflected a 32% decline in the
incidence of lung cancer in males between 1982 and 2007, and a concurrent 72% increase in
incidence in females during the same period of time (AIHW 2010).
The primary risk factor for lung cancer (particularly small cell carcinoma) is tobacco smoking,
which accounts for 90% of all diagnoses in males and 65% of all diagnoses in females (AIHW
2010). However, there are other notable risk factors for lung cancer which include:
1.

Second hand cigarette smoke

2.

Exposure to carcinogens (e.g. asbestos, diesel exhaust fumes)

3.

Radon exposure (naturally occurring radioactive gas released during normal decay of
uranium in rocks and soil)

4.

Family history of lung cancer

5.

A history of lung disease.

The relatively high incidence of lung cancer combined with the low survival rate means there is a
need to identify and develop effective strategies to aid prevention. One major strategy has been
anti-smoking policies and campaigns, given that smoking is the main risk factor for lung cancer
(AIHW 2010; Baldwin & Hubbard 2012). Smoking cessation campaigns have been implemented in
many countries, including Australia, and have been shown to be effective in reducing the ageadjusted incidence of lung cancer (Baldwin & Hubbard 2012).
However, a second strategy that requires considerable attention and development involves
improving the early diagnosis of lung cancer. It is generally agreed that this could be achieved
through a combination of screening interventions and, increasing public and health professional
awareness of lung cancer signs and symptoms (AIHW 2010, Hamilton et al. 2005). Unfortunately,
screening at a population level may not be an effective or efficient strategy at present given the
lack of reliable screening methods (Hamilton et al. 2005). Interventions aimed at increasing
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awareness of lung cancer signs and symptoms could be a more effective strategy for improving
the survival rate of lung cancer and are the primary focus of this review. The objective of this
rapid review is to examine the evidence regarding the effectiveness of these ‘signs and
symptoms’ interventions.

Lung cancer ‘signs and symptoms’
Lung cancer ‘signs and symptoms’ interventions have the potential to improve the early
diagnosis of the disease. This is important because the low survival rate of lung cancer can be
partially attributed to most patients being diagnosed at more advanced stages of the disease
(AIHW 2010). This is compounded by the low awareness of lung cancer signs and symptoms both
in the general community and amongst health professionals (Simon et al. 2012). Strategies for
increasing the recognition of signs and symptoms of lung cancer may be effective in improving
the survival rate for this disease.
The signs and symptoms of lung cancer vary depending on the stage and type of the disease.
However, the most common signs and symptoms are (Hamilton et al. 2005):
1.

A persistent cough which has lasted for three or more weeks

2.

Haemoptysis - coughing up blood

3.

Weight loss

4.

Loss of appetite

5.

Dyspnoea - subjective reports of breathing difficulties, including breathlessness

6.

Fatigue

7.

Chest or rib pain

8.

Finger clubbing – this refers to a thickening of the skin on the fingertips, leading to an
abnormal rounded appearance.

Many of these symptoms (e.g. a persistent cough) are commonly presented by patients visiting a
healthcare professional and quite often are indicative of another health condition (Hamilton et
al. 2005). However, when there is a co-occurrence of two of more of these symptoms, the
likelihood of lung cancer is increased dramatically (Hamilton et al. 2005).

The present review
A number of lung cancer ‘signs and symptoms’ interventions have recently been developed and
implemented, particularly in the United Kingdom (UK). The purpose of this rapid review is to review
available evidence regarding the effectiveness of these interventions. This involves addressing
two main questions:

Question 1
How effective are community-based ‘signs and symptoms’ interventions in influencing
knowledge, attitudes, beliefs, and help seeking behaviours in:
a.

The general community?

b.

Population groups at increased risk of developing lung cancer (e.g. smokers, individuals
with low socio-economic status, indigenous communities, rural and remote communities,
culturally and linguistically diverse communities)?

The Sax Institute
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Question 2
a.

How effective have lung cancer ‘signs and symptoms’ interventions for health
professionals been in influencing knowledge, attitudes, beliefs, and health professional
behaviours?

b.

What are the essential components of lung cancer ‘signs and symptoms’ interventions for
health professionals that have been effective?

In order to address these questions, we reviewed available academic and grey literature on lung
cancer ‘signs and symptoms’ interventions from Australia and OECD countries with similar
healthcare settings, particularly the UK, New Zealand and Canada. This rapid review involves
providing:
1.

An overview of available interventions and their characteristics

2.

A summary of the evidence of the effectiveness of these interventions

3.

An assessment of the quality of evidence for these interventions

4.

An indication of the factors influencing the success of these interventions (e.g. barriers
and enablers)

5.

Recommendations that can be used to develop similar interventions in NSW.

The effectiveness of these interventions is assessed in relation to the extent of:


Improvements in knowledge, attitudes and/or beliefs about lung cancer signs and
symptoms. Within this context, knowledge about cancer and its treatment is broadly
defined to include knowledge about causes, risk factors, incidence, detection, survival
rates, treatment options, and effectiveness of early detection



Increases in rates of early signs and symptoms recognition



Increases in rates of contact with healthcare professionals regarding signs and
symptoms.

It is noted that although several ‘signs and symptoms’ interventions have been implemented in
these countries, evaluation data are very limited. Therefore, reference is also made to ‘signs and
symptoms’ interventions developed for other cancers such as breast cancer, colorectal cancer,
and prostate cancer. Evaluation of these interventions will be useful in informing the
recommendations for future lung cancer interventions.

10
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2 Methods
Literature review
In order to address Questions One and Two, we reviewed recent (i.e. 2002–2012) academic
literature and grey literature to identify lung cancer ‘signs and symptoms’ interventions and
associated evaluation data. The methodology utilised for the literature search is outlined below.
1.

Academic Literature. A search of relevant academic literature published between 2002
and 2012 was conducted in the search engines Web of Knowledge (encompasses Web
of Science, Medline etc), Cochrane, Scopus, and Psycinfo using the following key words:


‘lung cancer’



AND



aware* OR prevent* OR cough OR breathlessness OR breath*



AND



campaign* OR program* OR intervention*.

The reference lists of identified articles were scanned for any additional relevant
publications that were not identified through the review.
2.

Grey Literature. The following websites from Australia, New Zealand, the UK, and
Canada were searched for relevant lung cancer ‘signs and symptoms’ interventions.


Australian Department of Health and Ageing



Australian state government health departments (e.g. NSW Ministry of Health,
VicHealth, SA Health, WA Health, Department of Health of the Northern Territory,
Queensland Health



Cancer Institute NSW



Cancer Council NSW



National Health Service (NHS) UK



Cancer Research UK



Canada Health



Canadian Cancer Society



NZ Ministry of Health.

A Google search was also conducted using the search terms for the academic literature search
in an attempt to identify other lung cancer ‘signs and symptoms’ interventions, not reported in
either body of literature.
Identified interventions were reviewed to derive information on:

-

The characteristics of the intervention (e.g. description of the intervention, formative
research, target groups, communication strategy, theoretical framework)

-

The evidence of the effectiveness of these interventions

-

An assessment of the quality of evidence for these interventions

-

Factors influencing the success of these interventions (e.g. barriers and enablers).

The Sax Institute
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Methods for assessing the quality of evidence
One of the aims of this rapid review was to assess the quality of evidence regarding the
effectiveness of ‘signs and symptoms’ interventions. In this review, the quality of data used to
evaluate these interventions was determined using the Grading of Recommendations
Assessment, Development, and Evaluation (GRADE) guidelines (Guyatt et al. 2011). This is a
system for rating the quality of evidence for published articles that are included in systematic
reviews.
More detail on this rating system is provided in Appendix A. However, in brief, this is a rating
system that assesses the quality of evidence from observational studies and RCTs against a
number of criteria (e.g. study design, imprecision, bias). Use of this rating system generates a
quality of evidence score for a given study ranging from very low quality to very high quality. The
four quality levels are described briefly.

12



High quality – very confident that the estimated effects are close to the true effects



Moderate quality – moderately confident that the estimated effects are close to the true
effects



Low quality – there is only limited confidence in the estimated effect



Very low quality – there is very little confidence in the estimated effect.

The Sax Institute

3 Results
Overview of lung cancer ‘signs and symptoms’ interventions
The review of the academic and grey literature identified eight interventions that made some
reference to lung cancer signs and symptoms. One of these interventions was published in the
academic literature – ‘I’ll tackle it soon’ (Athey et al. 2011). The remaining seven interventions
were identified through grey literature: ‘3 Week Cough’ (UK), ‘Be Clear on Cancer’, ‘Cough,
Cough, Cough’, ‘The Sooner the Better’, ‘The Australian Lung Foundation’ (various programs),
‘Find Cancer Early’, and ‘Detect Cancer Early’.
Furthermore, we identified three interventions that made some reference to lung cancer signs
and symptoms: ‘Cough On’ (Canadian Lung Association), ‘3 week Cough’ (NZ), and the
National Tobacco Campaign (Australia). These interventions were not included in the final list
given that they did not directly link signs and symptoms with lung cancer and/or did not
specifically have a relevant behavioural/attitudinal outcome (e.g. increase visits to a healthcare
professional).
Appendix B summarises the eight lung cancer ‘signs and symptoms’ interventions that were
included in this review. The key characteristics of these interventions are described below.
1. Goals of the intervention
As shown in Appendix B, the primary goal of all eight interventions was to raise awareness of the
signs and symptoms of lung cancer, and increase help seeking behaviour (often measured in
terms of the number of visits to the GP or other relevant healthcare professional). All of the
interventions targeted a persistent cough, typically lasting for 3 weeks or more. However, other
signs and symptoms of lung cancer were not targeted by these interventions. The only exception
was ‘Be Clear on Cancer’ which also aimed to raise awareness of other lung cancer signs and
symptoms such as coughing up blood, breathlessness, fatigue, and chest/shoulder pain.
There may be some advantage in targeting only a limited number of lung cancer signs and
symptoms. For example, research suggests that communication interventions are more effective
when the messages are simple. However, focusing on a single sign and symptom (persistent
cough) is a potential limitation of these interventions given that recognition of other symptoms
could also be very important. Therefore, future lung cancer ‘signs and symptoms’ interventions
may benefit from focusing on more than one symptom. These could include coughing up blood,
breathlessness, fatigue, and chest/shoulder pain, which were also publicised in the ‘Be Clear on
Cancer’ campaign.
2. Formative research
Only three of the eight interventions reported that they had conducted any formative research.
It is possible that the remaining interventions did conduct formative research but did not report
that they had done so. Hence, this review is only able to discuss formative research in relation to
the three interventions where this is reported.
The ‘I’ll tackle it soon’ intervention run by the NHS was informed by focus groups with members of
the community and consultations with relevant health professionals. The current ‘Be Clear on
Cancer’ intervention also run by the NHS has been based on extensive formative research. This
has included focus groups, as well as pilot testing in several smaller communities in the UK to test
feasibility. New Zealand’s ‘The sooner the better’ intervention, run in the northern regions of the
country, was also informed by extensive formative research. This included focus groups with
members of the community and consultations with clinicians and researchers.

The Sax Institute
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The remaining five interventions did not report whether formative research was conducted. This
may be a key limitation because formative research is considered important in ensuring that the
messages are being tailored appropriately to the target population. For example, it can provide
insight into what moves and motivates target populations, and how they might be reached and
influenced through awareness raising interventions. Pilot testing of messages and
communications with the target population is also useful to test the suitability and effectiveness of
intervention materials prior to launch. Therefore, it is recommended that any future intervention is
formulated on the basis of extensive formative research and pilot testing.
3. Target Groups
The eight interventions differed in regards to the groups that were targeted. One intervention
(‘Cough, cough, cough’) had no clear target group. Five interventions were targeted towards
middle aged adults (‘3 Week Cough’ and ‘I’ll tackle it soon’ were targeted at adults aged 50
years and over, ‘Be Clear on Cancer ‘ targeted at adults aged 55 years and over, ‘The sooner
the better’ Maori and Pacific Islanders aged 45-64 years, and ‘Find Cancer Early’ targeted adults
aged 40 years and over. In addition, the ‘Be Clear on Cancer’ and ‘I’ll tackle it soon’
interventions were also targeted towards individuals with lower socio-economic status. ‘The
sooner the better’ intervention is the only intervention we identified that is targeted towards a
specific ethnic group (Maori and Pacific Islanders). The ‘I’ll Tackle it Soon’ and ‘Cough, cough,
cough’ interventions reported that they also specifically targeted smokers. However, it should be
acknowledged that the majority of interventions targeted at risk populations in locations in which
smoking prevalence is high. The ‘I’ll Tackle it Soon’ intervention specifically did not mention
cancer or make reference to smoking to overcome barriers relating to fatalism about lung
cancer and stigma attached to smoking (Athey et al. 2011).
Segmentation and targeting of particular population groups is an important component of
effective awareness raising and health behaviour change interventions (Stead et al. 2007). This is
because various groups may have different attitudes, beliefs and behaviours, and hence may
respond different to messages and cues to action. Therefore, future lung cancer ‘signs and
symptoms’ interventions should include segmentation and targeting of different population
groups informed by the insights from formative research with the relevant audience. Importantly,
a more sophisticated segmentation approach with consideration for segmenting target groups
according to psychographic variables (e.g. attitudes, beliefs) as well as demographic variables
(particularly socio-economic status and CALD) should be adopted in lung cancer ‘signs and
symptoms’ interventions. Interestingly, the current review found no direct evidence of
psychographic segmentation in the available literature; it is possible that this was examined in
some interventions but has not been published.
4. Theory
None of the interventions were reported to have been informed by relevant theory. Consistent
with the discussion surrounding formative research and psychographic segmentation, it is possible
that at least some of the interventions did use theoretical frameworks but did not report this
information. This is a common occurrence in many health interventions, whereby relevant
theories are used but are not reported in academic or grey literature.
Use of relevant theories such as the Theory of Planned Behaviour and the Health Belief Model is
important as it provides a useful framework for understanding health behaviours such as seeking
help from a health professional (Glanz et al. 2008). As noted in more detail below, ‘signs and
symptoms’ interventions that have been developed for other cancers have used frameworks
such as social cognitive theory (Bandura, 1988) to inform messages and materials. We
recommend that future lung cancer ‘signs and symptoms’ interventions also incorporate relevant
behaviour theories.

14
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5. Communication Strategy
Most of the interventions delivered messages through a variety of media including:



Face-to-face events such as road-shows in public venues such as shopping centres
featuring media personalities, information and campaign materials (e.g. ‘Be Clear on
Cancer’) linked in with existing events such as fetes, sports activity and open days



Radio and television advertising



Posters and Billboards



Online through campaign and relevant stakeholder’s websites, and social media such as
e-bulletins, e-newsletters, Twitter feeds, Facebook pages, and articles disseminated on
social media sites (e.g. ‘Be Clear on Cancer’ and ‘3 Week Cough’)



Leaflets.

The most comprehensive communication strategy has been adopted by the ‘Be Clear on
Cancer’ intervention which, as a national campaign, uses multiple communication channels on
a large scale. Other interventions implemented on a smaller scale utilised less expensive media
such as newspaper articles, leaflets, and online information. Unfortunately, this level of detailed
information is not included in the publications identified in the review. Exploratory research and
pre-testing should be able to propose/identify suitable channels of communication with the
target audience(s).
6. Outcomes
One of the major limitations of the existing literature is that there is a lack of evaluation data
examining effectiveness of lung cancer ‘signs and symptoms’ interventions. Only two of the lung
cancer ‘signs and symptoms’ interventions have corresponding evaluation data – ‘I’ll tackle it
soon’ and ‘3 Week Cough’ – of which only the results of ‘I’ll tackle it soon’, have been published
in peer reviewed literature (Athey et al. 2011). Both interventions were linked, as they were
administered under the NHS framework, and learning from these interventions was used to
develop the national ‘Be Clear on Cancer’ intervention.
‘I’ll tackle it soon’ was a community based social marketing intervention to raise awareness of
lung cancer signs and symptoms, and increase presentations for healthcare (Athey et al. 2011).
Social marketing is defined as the “the systematic application of marketing, alongside other
concepts and techniques, to achieve specific behavioural goals for a social good” (French and
Blair-Stevens 2007). The intervention was conducted among six at-risk communities with high
levels of smoking prevalence, and low socio-economic status in Doncaster, England during 2008.
The main target group was males aged over 50 who had ever smoked and worked in heavy
industry, and their family members. It featured core social marketing intervention criteria
including customer orientation and insight generated through formative research, segmentation
and targeting, addressing the competition (e.g. barriers to the desired behaviour), and use of the
marketing communications mix. Formative research identified a number of issues and barriers to
awareness of, and presentation to a health worker in relation to, lung cancer signs and
symptoms. These included a lack of clarity and understanding of symptom experience, a lack of
knowledge of lung cancer signs and symptoms, and fear including a lack of knowledge of
treatments and fatalistic beliefs. Blame and stigma attached to smoking were also powerful
influences. Cultural factors such as stoicism, and an unwillingness to complain, waste time or use
healthcare resources unnecessarily, were also identified. The formative research also revealed
that the role families played could be crucial in overcoming delays in recognising signs and
symptoms and presenting for assessment and treatment.
Exploratory research for ‘I’ll Tackle it Soon’ also identified that there were concerns among
primary caregivers over becoming overloaded with referrals, the risks associated with x-rays, and
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confusion over when to re-refer if an x-ray was normal but symptoms persisted. Furthermore, in
the secondary care setting there was concern over capacity in radiology and along the lung
cancer pathway (Tod et al. 2008).
The intervention was designed and delivered to account for the insights generated from the
formative research. The project aimed to increase the number of symptomatic patients
presenting at GP surgeries and to increase x-ray referrals by 20%. Two complementary
interventions were developed, with a push-pull approach being utilised. The present element
included a public awareness media campaign, media and public relations activities such as
face-to-face events and conversations focusing on raising awareness of the importance of
seeking help and advice for a cough lasting more than three weeks.
A three week cough was selected as the focus due to evidence suggesting it may be associated
with a better prognosis and to ensure simplicity of the message. In addition, focusing on this
symptom is useful because if the cough is not a sign of cancer (or another serious disease) then it
would normally resolve with antibiotics within three weeks. Intervention messages informed by the
formative research did not specifically mention cancer, or smoking, addressing barriers to help
seeking behaviour. The pull element of the intervention included brief intervention training to
prepare healthcare workers for the intervention and reassure them of capacity in the system.
Extensive training was conducted with community pharmacists, GP practices and other
healthcare workers involved in the lung cancer pathway.
The evaluation data indicated that 21% of the target population (128/600) recalled the
intervention. Compared with a respondent in the control area, a participant in the intervention
area was 1.97 times more likely to indicate they would visit their general practitioner and request
a chest x-ray for a cough. Primary care chest x-ray referral rates increased by 20% in the targeted
practices in the year following the intervention compared with a 2% fall in the control practices;
this difference was statistically significant. There was a 27% increase in lung cancer diagnoses in
the intervention area compared with a fall in the control area. Evaluation of the intervention did
not report data regarding the effectiveness of the intervention on attitudes, beliefs, or knowledge
regarding lung cancer signs and symptoms.
The second intervention for which we identified evaluation data was the ‘3 Week Cough’
intervention, which was a five week pilot study to increase awareness of lung cancer signs and
symptoms conducted in the Midlands of England in 2011. The intervention was targeted at adults
aged 50 years and over. The intervention aimed to increase visits to a GP among the target
population when aware of suspected signs and symptoms of lung cancer. Although formative
research was not reported in the literature, the intervention was linked to the previous ‘I’ll tackle it
soon’ study in Doncaster, and could therefore be assumed to use learning and insights from it.
The intervention featured a mass media campaign using television and radio advertising, posters
in GP surgeries, and face-to-face events in the community. This involved brief intervention training
of health professionals, community pharmacists, community development workers, and cancer
information workers; as well as community influencers such as community leaders, community
champions and volunteers, who were tasked with having conversations about a 3 week cough
with the target audience and advise people how to act.
It was not reported whether the intervention utilised behavioural theory. Evaluation of the
intervention found that it was responsible for a 23% increase in GP attendances for patients with a
cough or suspected of having lung cancer.
Data identifying factors influencing the effectiveness of these interventions were not reported.
Furthermore, it is not clear whether these interventions were more or less effective in CALD
communities or among individuals from different socio-economic backgrounds.
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‘Signs and symptoms’ interventions – breast, colorectal, and
prostate cancer
Given the lack of evidence regarding lung cancer ‘signs and symptoms’ interventions and
accompanying evaluation data, we supplemented the review by conducting additional
literature searches to identify published ‘signs and symptoms’ interventions for:


Breast cancer



Colorectal cancer



Prostate cancer.

Search strategy
A search was conducted for relevant academic review articles published between 2002 and
2012 in the search engines Web of Knowledge (encompasses Web of Science, Medline etc),
Cochrane, Scopus, and Psycinfo using key words such as:


‘breast cancer’ OR ‘bowel cancer’ OR ‘colorectal cancer’ OR ‘colon cancer’ OR
‘prostate cancer’



AND



aware* OR prevent* OR signs OR symptoms



AND



campaign* OR program* OR intervention*.

From these searches we identified one relevant systematic review of interventions to promote
cancer awareness and early presentation (Austoker et al. 2009), which included evaluation of
four breast cancer interventions (Rimer et al. 2002; Skinner et al. 2000; Catalano et al. 2003 and
Gabram et al. 2008). We also identified one further breast cancer intervention with a signs and
symptoms component (Linsell et al. 2009). Therefore, a total of five breast cancer interventions
were included in the review.
We identified four colorectal cancer interventions featuring a signs and symptoms component for
inclusion in the review: ‘Be Clear on Cancer’, ‘Screen for Life’ (Jorgensen et al. 2001), ‘West of
Scotland Cancer Awareness Project’ (WoSCAP) (Eadie and MacAskill 2002, 2008) and a
colorectal cancer intervention developed by Broadwater et al. (2004).
In addition, we identified two interventions for prostate cancer which featured a signs and
symptoms component: Lyzun and McMullen (2008), and Ilic et al. (2007).
In summary, from these additional searches we identified 11 interventions, five breast cancer, four
colorectal cancer, and two prostate cancer interventions containing a signs and symptoms
component, the results of which are presented in Appendix C.
Rather than reviewing all of these interventions in detail, we present a rapid review of key
features pertaining to breast, colorectal and prostate cancer interventions with a signs and
symptoms component for which published evaluation data are available.
1. Behaviour change goal
The behaviour change goals varied between the interventions, which is not surprising given that
the aims and scope of these interventions were also quite different. Six of the 11 interventions
were targeted towards increasing health seeking behaviours. In particular, four interventions
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aimed to increase the number of visits to a healthcare professional (e.g. a GP) for symptoms
associated with the relevant cancer. Two of the interventions aimed to increase screening
behaviours (e.g. mammography). Another common goal of these interventions was to increase
awareness of cancer (including signs and symptoms); this was reported in five of the 11
interventions. The other interventions had goals such as increasing the rates of detection (3/11
interventions).
2. Formative research
Nine of the 11 interventions indicated that they had performed some formative research; this
varied from a simple literature review to in-depth consultations with relevant stakeholders and
testing of intervention materials.
Formative research indicated that awareness of cancer signs and symptoms is low, particularly in
low socio-economic or CALD communities (e.g. Eadie and MacAskill 2002). Furthermore,
concerns about embarrassment, putting unnecessary strain on the healthcare system, and
fatalistic beliefs about cancer can act as barriers to action by target populations. Interventions
that conducted extensive formative research with the target audience enabled segmentation
and targeting strategies to be deployed (e.g. Rimer et al. 2002). This provided tailored print
materials and telephone counselling to participants based on data from a baseline telephone
interview. Therefore, formative research can often be vital in generating insight on the target
audience’s knowledge, attitudes and behaviours, identifying barriers to behaviour change, and
exploring themes that can inform intervention messages and materials. Interventions that are
able to take a more sophisticated segmentation and targeting approach, beyond simple
demographic breakdowns and involving psychographic segmentation, have also been shown to
be effective (Jones et al 2010).
3. Target Groups
The specific groups targeted in these interventions varied quite considerably. This is not surprising
given the different target cancers (e.g. prostate versus breast cancer) and the intervention
settings. Despite these variations, a key finding is that the majority of these interventions clearly
identified a target group. For example, several of the interventions identified groups on the basis
of age, particularly middle aged and older adults; socio-economic status, predominantly low
socio-economic groups (Mayden Research 2012); ethnicity such as African-American women
(Gabram et al. 2008); and/or geography, a specific city or region such as the West of Scotland
(Eadie and MacAskill 2002).
4. Theory
Five of the 11 ‘other cancer’ interventions identified made use of behavioural theories. The
relevant theories are briefly outlined below.
One intervention (Rimer et al. 2002) used the Transtheoretical Model (Prochaska and DiClemente
2005). This model proposes the following five stages of change that need to be negotiated when
trying to encourage a new health behaviour:
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1.

Pre-contemplation: People are not intending to take action for the foreseeable future

2.

Contemplation: People are intending to take action in the next six months

3.

Preparation: People are intending to take action in the immediate future

4.

Action: People have made changes to their lifestyles in the past six months

5.

Maintenance: People are trying to prevent relapse to previous behaviour(s).
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The theory also proposes a termination stage, whereby a person has fully adopted the new
behaviour and will not return to the old behaviour. However, this is a theoretical concept, since
very few people will ever reach this stage.
The WoSCAP utilised Social Cognitive Theory (Bandura 1988), to inform their intervention. This
model proposes that individuals learn behaviour through their interactions with other people in
their social network and by observing other people (e.g. people on television). Observing these
‘models’ can influence an individual’s attitudes regarding a behaviour, which can translate into
changes in behaviour. Social Cognitive Theory also incorporates psychological constructs such as
self-efficacy and outcome expectancies, which also influence the adoption of behaviours.
Skinner et al. (2000) used a combination of Social Cognitive Theory and the Health Belief Model
(see Rosenstock 1966); the latter is a psychological model used to predict health behaviours. The
model is based on four constructs of the core beliefs of individuals, based upon their perceptions.
1.

Perceived susceptibility (a person’s view on their risk of getting the condition)

2.

Perceived severity (a person’s view of the seriousness of the condition and the
consequences)

3.

Perceived barriers (a person’s view of the factors that facilitate or discourage adopting
the promoted behaviour)

4.

Perceived benefits (a person’s view of the positive consequences of adopting the
behaviour).

The Screen for Life intervention used a combination of Social Cognitive Theory and the Theory of
Planned Behaviour (Ajzen 1991). The Theory of Planned Behaviour is a widely used theory to
understand and predict behaviour across of variety of domains. The model proposes that an
individual’s behaviour is the result of:
1.

The individual’s attitude towards the behaviour

2.

The individual’s perceptions of how other people (e.g. friends, family, work colleagues
etc) feel about the behaviour (subjective norms)

3.

How confident the individual feels about engaging in the behaviour (perceived
behavioural control)

4.

Intentions to engage in the behaviour.

One intervention (Linsell et al. 2009) used a theoretical model developed by Bish et al. (2005). This
theoretical model aimed to understand some of the factors that influence help seeking
behaviours in the context of breast cancer symptoms. The authors developed a model whereby
they attempted to explain how attitudes, intentions, and knowledge of symptoms interacted to
influence help seeking behaviours.
5. Communication strategy
The communication strategies adopted by the interventions also varied considerably depending
on the scope of the intervention, the target groups, and the target cancer. For example, the
Australian intervention tested by Ilic et al. (2007) involved distributing educational materials to
male patients attending a medical centre. In contrast, other interventions such as ‘Be Clear on
Cancer’, the WoSCAP, and ‘Screen for Life’ utilised a variety of communication channels that
aimed to reach a variety of audiences including the target group, friends and family,
pharmacies, and a variety of healthcare workers involved in the cancer treatment pathway
including GPs, consultants, nurse specialists and radiographers. For example, in support of the ‘Be
Clear on Cancer’ intervention, Bowel Cancer UK and the Royal College of General Practitioners

The Sax Institute

19

RESULTS

(RCGP) developed a new bowel cancer resource pack which was sent to GPs across the two
regions in which the intervention was piloted.
Communication strategies identified in the interventions identified included:


Television and radio advertising



Posters



Public relations events



Brochures and fact sheets



Training of healthcare workers



Stakeholder engagement



Peer educators



Websites



Physical products – e.g. testing kits.

6. Outcomes
In general, most of the interventions had positive outcomes. Several of the interventions led to
significant improvements in knowledge and awareness of cancer signs and symptoms. For
example, the ‘Be Clear on Cancer’ intervention which was aimed towards colorectal cancer led
to an approximate 50% increase in awareness of symptoms (e.g. ‘blood in poo’).
Several of the interventions also led to significant increases in cancer screening behaviour.
‘Learn, Share and Live’ led to an increase in the percentage of women who indicated that they
had recently been screened for breast cancer (from 40% to 68%). ‘Screen for Life’ was
associated with a 19.3% increase in screening rates for colorectal cancer between 2002 and
2008; there was also evidence for increases in visits to healthcare professionals. ‘Be Clear on
Cancer’ led to a 48% increase in GP visits for colorectal cancer signs and symptoms.
Unfortunately, the quality of the evaluation data was generally low. Four of the interventions had
a high level of quality, whereas six had low quality and one had very low quality. Therefore,
although these interventions generally had positive effects on the outcome measures these need
to be interpreted with caution. In particular, there is a need for more rigorous research designs
(e.g. RCTs or well-developed observational studies) to better determine the effectiveness of these
interventions. Furthermore, as per the lung cancer ‘signs and symptoms’ interventions, evaluation
data did not identify factors that influenced the effectiveness of these interventions, or whether
effectiveness varied according to socio-economic or CALD status.
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4 Discussion
This rapid review was conducted to identify lung cancer ‘signs and symptoms’ interventions from
Australia, New Zealand, Canada, and the UK. There were two main findings from this review.
First, there are few very ‘signs and symptoms’ interventions for lung cancer that have been
developed and trialled in these countries. All eight interventions identified were targeted
specifically towards members of the general community (Question 1) and only contained
components targeted towards health professionals – ‘I’ll tackle it soon’ – (Question 2), which
aimed to increase awareness of, and preparedness for, the intervention amongst health
professionals. Training also reassured healthcare workers that there was sufficient capacity in the
system to deal with increases in presentation and treatment. Second, evaluation data for these
interventions are very scarce. For example, of the eight relevant interventions identified, only two
had evaluation data. Furthermore, the data were published for only one of these interventions
(‘It’ll go soon’) and the quality of the evidence was low.
The lack of data for lung cancer ‘signs and symptoms’ interventions led to an expansion of the
literature search to also include other cancers such as breast, colorectal, bowel, and prostate
cancer. Although evaluation data were available for several of these interventions, the evidence
base remains limited. Therefore, although this rapid review does attempt to provide
recommendations for the development of future lung cancer ‘signs and symptoms’ interventions
within the NSW context, it is emphasised that these are based on very limited data. Therefore, the
recommendations and conclusions should be treated with caution, and we would strongly
encourage any future interventions to utilise formative research with the target audiences to
inform their design and implementation.
We are able to draw the following conclusions based on available data:

Question 1
How effective are community-based ‘signs and symptoms’ interventions in influencing
knowledge, attitudes, beliefs, and help seeking behaviours in:
a.

The general community?

b.

Population groups at increased risk of developing lung cancer (e.g. individuals with low
socio-economic status, indigenous communities, rural and remote communities, CALD)?

‘Signs and symptoms’ interventions may be effective influencing knowledge, attitudes, beliefs
and help seeking behaviours (e.g. seeking help from a GP, screening behaviours). However the
evidence base is limited, especially in relation to lung cancer, with some limited evidence from
other cancer interventions suggesting a positive effect. Further published intervention studies are
required to build the evidence base in this regard.
There is very limited evidence (whether published in academic journals or reported in grey
literature) regarding the effectiveness of lung cancer ‘signs and symptoms’ interventions
targeted towards at risk population groups. There is reasonable evidence to suggest that ‘signs
and symptoms’ interventions for other cancers can increase levels of knowledge, attitudes,
beliefs, and help seeking behaviour among low socio-economic groups. There is limited evidence
that such interventions can increase levels of health seeking behaviour among CALD
communities (e.g. African America women), however there is a paucity of published research.
Unfortunately, there are insufficient data to identify factors affecting the effectiveness of
interventions targeting rural and remote communities, and the majority of interventions included
in the review were in urban or suburban environments.
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Further exploratory research is required to investigate knowledge, attitudes, behaviours, and
barriers in relation to awareness of lung cancer signs and symptoms and cues to action. Some of
these barriers may include: lack of clarity and understanding of symptoms experience, lack of
knowledge of lung cancer signs and symptoms, fear including a lack of knowledge of treatments
and fatalistic beliefs. Stigma and cultural influences including stoicism, an unwillingness to
complain, waste time or use healthcare resources unnecessarily may also be additional barriers.
Families and significant others could also be crucial in overcoming delays in recognising signs
and symptoms and presenting for assessment and treatment (Athey et al. 2011).
Several cancer interventions included in the review utilised a social marketing approach to
behaviour change including ‘I’ll tackle it soon’, WoSCAP, ‘Detect Cancer Early’ and ‘Prostate
Man’. Furthermore, other interventions such as ‘Be Clear on Cancer’ used social marketing
principles such as using formative research to gain insight, and taking a consumer (patient)
oriented approach to behaviour change, but were not explicitly described as social marketing.
It is likely that ‘Be Clear on Cancer’ is not overtly described as social marketing due to the
change in UK Government in 2010 and the interest in ‘Nudge Theory’ (or ‘Behavioural
Economics’) which is favoured by the government. This has led to less visible support for social
marketing from policy makers.

Question 2.
a.

How effective have lung cancer ‘signs and symptoms’ interventions/campaigns for
health professionals been in influencing knowledge, attitudes, beliefs, and health
professional behaviours?

b.

What are the essential components of lung cancer ‘signs and symptoms’
interventions/campaigns for health professionals that have been effective?

There is insufficient evidence to make any conclusions regarding interventions targeted towards
health professionals. Increasing awareness among healthcare workers and addressing concerns
over capacity and protocol for x-rays and treatment were components of the ‘I’ll tackle it soon’
intervention. However, outcome evaluation from this intervention did not measure any impact on
knowledge, attitudes, beliefs and health professional behaviours.
Interventions for other cancers such as WoSCAP successfully engaged a range of stakeholders in
the process of delivering the intervention which appear to contribute to its success. Process
evaluation of WoSCAP (Cancer Research UK 2007) outlines how an internal social marketing
approach (see Smith and O’Sullivan 2012) was effective at co-opting over 45,000 healthcare
workers including clinicians, GPs, pharmacists, NHS management, public health consultants and
health promotion staff across the region.
With respect to question 2b, formative research that informed the development of the ‘I’ll tackle
it soon’ intervention (see Suckling 2010) identified that there were concerns among healthcare
workers on the implications of running a lung cancer signs and symptoms awareness intervention.
There were concerns over becoming overloaded with referrals, over the risks associated with xrays and radiation exposure, and there was confusion over when to re-refer a patient if an x-ray
was normal but their symptoms persisted. In addition, there were concerns over capacity in
radiology, and more generally along the lung cancer pathway (Tod et al. 2008). The ‘I’ll tackle it
soon’ intervention addressed these issues through awareness raising and training with healthcare
workers. Therefore, from this limited evidence, it could be suggested that future interventions
should investigate whether similar concerns, and ways of addressing them, are present.
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5 Gaps in the literature
As discussed earlier, further research is required to generate greater understanding and insight on
the issues, influences on, and barriers in relation to awareness of lung cancer signs and symptoms
and presentation for advice and help. Currently, there is little published formative research with
at risk populations regarding lung cancer, and their awareness of signs and symptoms of the
disease. Indeed, the entire area of lung cancer ‘signs and symptoms’ awareness raising
interventions is relatively new, with further evidence likely to become available in the coming
months and years. Additional studies which conduct exploratory research will contribute
considerably to the evidence base.
In addition, there is little in the extant literature regarding the segmentation of target populations
according to psychographic variables. Existing interventions do not appear to have made
judicious use of behavioural theory to inform development and implementation. Furthermore,
there is evidence from other cancer interventions that using theory is useful for informing
intervention messages and materials.
The majority of data currently available is from the UK, therefore interventions in other countries
would be useful to build the evidence base, and assess the effectiveness of lung cancer ‘signs
and symptoms’ interventions in other domains. There is also little evaluation data currently
available in this area, and little to none on process evaluation and cost effectiveness. Therefore,
future interventions that include a comprehensive evaluation framework providing data on
process, outcomes and cost effectiveness would be helpful.
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6 Recommendations
The following recommendations are made based on the findings of the review, to inform the
development of lung cancer ‘signs and symptoms’ interventions in NSW.
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1.

Interventions should be based on rigorous formative research with target population
groups and stakeholders to generate understanding and useful insights regarding
knowledge, attitudes, and behaviours, and to explore issues, influences and barriers to
increasing awareness and changing behaviour

2.

Segmentation of target populations – beyond simple demographic based approaches
but using formative research to identify psychographic audience segments will enable
targeted and tailored intervention messages and communication channels and
materials to be used

3.

Capacity building and training with relevant stakeholders such as community members
and healthcare professionals can be helpful to alleviate concerns over resources and
build support for intervention aims and objectives

4.

Future interventions would benefit from the use of relevant theories to help identify
relevant factors influencing behaviour, and to develop strategies to change behaviours

5.

There is a need to develop and test interventions targeting specific at-risk groups

6.

Evaluation research models which include process, and cost effectiveness, as well as
outcome evaluation data, should be built in at the start of future interventions, as existing
interventions do not report these data

7.

Social marketing offers a comprehensive and strategic framework for incorporating the
aforementioned recommendations, and has been demonstrated to be an effective
approach for colorectal cancer (Cancer Research UK 2007), and more widely for
population health behaviour change interventions (Stead et al. 2007). In addition, utilising
an internal social marketing approach—the application of internal marketing for the
achievement of social rather than commercial objectives (Smith 2011), to engage
relevant stakeholders in the healthcare sector can overcome barriers such as concerns
over capacity and support in the system; and issues over procedures and protocols

8.

There is also a need to work with a range of agencies to expand the knowledge base
surrounding lung cancer signs and symptoms.
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Appendix A. Quality grading
The Grading of Recommendations Assessment, Development, and Evaluation (GRADE)
guidelines (Guyatt et al. 2011). This is a system for rating the quality of evidence in systematic
reviews and takes into account:
1.

Study design – randomised controlled trials receive a higher initial quality score
compared with observational studies

2.

Risk of Bias – there can be a risk of misleading results if the study design or conduct is
flawed (e.g. poorly developed eligibility criteria, failure to control for confounding)

3.

Imprecision – optimal approach to imprecision is the examination of the 95% confidence
interval (CI). CI informs the impact of random error on the evidence quality

4.

Inconsistency – a body of evidence is not rated up in quality if studies yield consistent
results but may be rated down in quality if inconsistent

5.

Indirectness – evidence can be indirect in 4 ways. Patients may differ from those of
interest, tested intervention may differ from intervention of interest, outcomes (or
‘surrogate outcomes’) differ from those of primary interest and when clinicians must
choose between interventions. When there is no head to head comparison of the study,
the quality of evidence decreases as the use of indirect comparison is needed. Rating
down occurs when there is a large discrepancy between these 4 points of indirectness

6.

Publication bias – even if individual studies are perfectly designed and executed,
synthesis of studies may provide biased estimates. This is partly since there may be a bias
in journals publishing negative or no results (eg. overestimating effect size)

7.

Rating up the quality of evidence – most common reason is evidence of a large effect.
Rate up 1 level if study shows at least a 2-fold reduction or increase in risk, and rate up 2
levels for at least a 5-fold reduction or increase in risk. Consider rating up if a systematic
review shows evidence of a dose response gradient. Need to consider other criteria for
rating down quality of evidence before employing this concept though.
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Appendix B. Lung cancer interventions with a ‘signs and symptoms’ component
Campaign
I’ll tackle it soon
(NHS)

Country and
Year
UK, 2008

Athey et al. 2011.
Tod et al. 2008.

Description of Campaign
This was a pilot awareness raising campaign
implemented in Doncaster (UK) in early 2008. The
campaign involved two complementary components.
The push element involved a public awareness
campaign that focused on raising awareness of the
importance of seeking medical advice and requesting
a chest x-ray for a cough lasting more than 3 weeks.
The pull aspect involved brief interventions to
prepare healthcare professionals for the intervention
and to assure them that there was sufficient capacity
to deal with the increased referrals.

Campaign Characteristics
1. Behaviour Change Goal: increase visits to GP and x-ray referrals
2. Formative Research: Focus groups, consultations with health professionals
3. Target Groups: six at risk communities with high smoking rates and low socioeconomic status in Doncaster, England. Specifically targeted at men over 50
years who had ever been smokers and worked in heavy industry and their
family members
4. Theory: not reported but did use the five elements model of strategic
community engagement: grassroots community work, community
infrastructure, professional infrastructure, organisation development, and
overview and coordination

Results
20% increase in chest
x-rays.
Significant increase in GP
visits.
27% increase in lung
cancer diagnoses.
Quality of evidence: Low
(controlled trial – no
randomisation).

5. Communication Strategy: utilised a range of media such as newspapers,
leaflets, radio, and billboards, face-to-face events, and conversations.
3 Week Cough (NHS)
Suckling 2010.
Elliott & Stacey 2010.

UK, 2011

Five week pilot campaign trialled in the Midlands
(UK) in 2011. The campaign aimed to increase
awareness of lung cancer signs and symptoms.

1. Behaviour Change Goal: increase help seeking behaviour (e.g. increased
presentations to a GP)
2. Formative Research: not reported

23% increase in GP
attendances for patients
with a cough or suspected
of having lung cancer.

3. Target Groups: Adults aged 50 years and over
4. Theory: not reported
5. Communication Strategy: utilised a range of media including television, radio,
out of home advertising (e.g. TV screens in GP surgeries) and face-to-face
event.

Quality of evidence: low.

Lung cancer interventions with a ‘signs and symptoms’ component

Campaign
Be Clear on Cancer
(NHS)

Country and
Year
UK, 2012

Freud
Communications
2012

Cough, cough, cough
(Midland Cancer
Network)

NZ, 2010

http://tinyurl.com/8d
pupu2

The sooner the better
(Northern Cancer
Network)
http://tinyurl.com/9n
k2qd8

29

NZ, 2010

Description of Campaign

Campaign Characteristics

This two month campaign is part of a larger national
cancer awareness campaign, addressing breast, lung,
bowel, and prostate cancer. The key messages of
the lung cancer campaign focus on the importance of
early detection of lung cancer. It also aims to
increase awareness of lung cancer signs and
symptoms (e.g. coughing up blood, persistent cough,
breathlessness, fatigue, chest/shoulder pain).

1. Behaviour Change Goal: increase visits to GP

Awareness raising campaign aimed at improving the
early detection of lung cancer in Rotorua, NZ. This
was based on a push-pull model. In the push
element, the aim was to encourage individuals
(especially smokers) with a persistent cough to see
their doctor. In the pull element, health care
workers were encouraged to promote the early
detection of lung cancer and seek help earlier.

1. Behaviour Change Goal: increase visits to GP and health professionals

Campaign aimed at increasing awareness of lung
cancer symptoms in Maori and Pacific populations.
The campaign involved outlining the main symptoms
of lung cancer (e.g. persistent cough, chest pain,
persistent chest infection, coughing up blood).
Individuals with these symptoms were encouraged
to contact their nurse, doctor, local health worker, or
the Healthline phone number. GPs and other health
care workers were advised of the program.

1. Behaviour Change Goal: increase visits to nurse, doctor, local health worker, or
Healthline phone number

Results
Not reported.

2. Formative Research: Informed by pilot studies (e.g. 3 week cough)
3. Target Groups: Adults aged 55 years and over, with a focus on individuals from
lower socio-economic groups
4. Theory: not reported
5. Communication Strategy: television, radio, print, online, and social media, with
face-to-face events, and national and regional PR activity. Material also
developed for GPs to prepare them for the increase in referrals and to gain
their support in increasing screening for lung cancer.
Not reported.

2. Formative Research: not reported
3. Target Groups: Smokers
4. Theory: not reported
5. Communication Strategy: There is only very limited information regarding the
specific communication strategy adopted in this campaign. However, it
appears that the campaign was based on posters and brochure material
promoting the importance of seeking help from a health professional in
response to a persistent cough.
Not reported.

2. Formative Research: focus groups with target audience, and consultations with
clinicians and researchers
3. Target Groups: Adults aged 45–64 years with Maori and Pacific backgrounds.
4. Theory: not reported
5. Communication Strategy: this campaign included a combination of radio
advertisements and newspaper articles disseminated across specific areas of
Northern New Zealand.
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Campaign
The Australian Lung
Foundation (various
campaigns)

Country and
year
Australia, 2011

http://www.lungfoun
dation.com.au/shinea
lightonlungcancer

Description of Campaign

Campaign Characteristics

The Australian Lung Foundation ran a variety of
campaigns to raise awareness of lung cancer in 2011;
these coincided with Lung Health Awareness month
in 2011 and World COPD day. These campaigns
included ‘Lung Cancer Doesn’t Discriminate’, ‘Shine a
Light On Lung Cancer’, and ‘Show us your lungs’.

1. Behaviour Change Goal: increase lung cancer screening (i.e., increase GP visits)

Scottish Government
2011.

2. Formative Research: Not reported
3. Target Groups: No clear target groups, but appeared to be focused on smokers
and individuals exposed to asbestos

5. Communication Strategy: This varied depending on the campaign. These
included face-to-face events, posters, and online information (through the
Australian Lung Foundation website).
Australia, year
not reported

http://tinyurl.com/9w
669ep

Detect Cancer Early
(NHS)

Not reported.

4. Theory: not reported

http://www.lungfoun
dation.com.au/showu
syourlungs
Find Cancer Early
Cancer Council WA

Results

Scotland, lung
cancer
component
planned for
2013

Two-year campaign aimed at increasing awareness
of the signs and symptoms of bowel, lung, prostate,
and breast cancer in adults aged 40 years and over in
regional WA. The campaign aimed to increase
awareness of the main symptoms, and encourage
people to visit their doctor. The lung cancer
component focused on the following symptoms: a
persistent cough, coughing up blood, breathlessness,
repeated chest infections.

1. Behaviour Change Goal: increase visits to GP

A social marketing campaign aimed at overcoming
the fear associated with cancer and improving
awareness levels of cancer signs and symptoms. The
campaign is targeted at breast, lung, and bowel
cancer.

1. Behaviour Change Goal: increase visits to GP

2. Formative Research: not reported
3. Target Groups: Adults aged 40 years and over, residing in regional WA
4. Theory: not reported
5. Communication Strategy: The communication strategy was primarily based on
DVD, posters and brochures which were distributed to members of the
community in the target group.

2. Formative Research: not reported
3. Target Groups: not reported
4. Theory: not reported
5. Communication Strategy: Detect Cancer Early is a large social marketing
campaign that includes a lung cancer component which will begin in 2013.
Specific details of the lung cancer component are not yet available.

Lung cancer interventions with a ‘signs and symptoms’ component

Not reported.

Not reported.

Appendix C. Breast, colorectal and prostate cancer interventions with a signs
and symptoms component
Campaign

Setting and
year

Description of Campaign

Campaign Characteristics

Results

Breast Cancer
Catalano et al. 2003.

USA, data
collected from
Atlanta, Detroit
and San
Francisco
metropolitan
areas from
1985–2002

Evaluation of the impact of the Breast Cancer
Awareness Month programme on awareness
of breast cancer symptoms, and screening and
detection of breast cancer. Breast Cancer
Awareness Month is a national mass media
campaign focusing on breast cancer awareness
and screening, targeting large populations. The
campaign has national and local components,
and involves a number of partner stakeholders.

1. Behaviour Change Goal: No reported outcomes measures for
awareness of signs and symptoms of breast cancer – only reports
rates of detection of breast tumours

No data reported in relation to signs and
symptoms of breast cancer.

3. Target Groups: not reported – targeted at large populations of
females

Evaluation reported that during Breast
Cancer Awareness month quarters of the
year from 1985–2002 approximately 790
more tumours than expected were
detected.

4. Theory: not reported

Quality of evidence: High.

2. Formative Research: Not reported

5. Communication Strategy: National and local media campaign
involving PR/media relations, print advertising and TV advertising.
Gabram et al. 2008.

USA , Atlanta
Georgia 2001–
2004

A community outreach and internal navigation
programme to improve outcomes in relation to
breast cancer among African America women.
125 trained community health advocates
(CHAs) provided educational programmes to
the community to encourage screening,
diagnostic procedures (including recognising
signs and symptoms) and treatment.

1. Behaviour Change Goal: No reported outcome measures for
awareness of signs and symptoms of breast cancer – only reports
rates of detection of breast cancer
2. Formative Research: Not reported
3. Target Groups: African America females in Georgia, Atlanta
4. Theory: not reported
5. Communication Strategy: CHAs provided educational sessions in the
community encouraging screening, increase breast cancer
awareness, teach the importance of self examination and
encourage participants to see a trained healthcare provider if any
symptoms were found.

31

No data reported in relation to signs and
symptoms of breast cancer.
487 patients were diagnosed and treated
for breast cancer 2001–2004. Since 2001,
there were 1148 community
interventions by CHAs reaching, >10,000
participants. From 2001–2004 the
proportion of stage 0 breast cancers
increased from 12.4% to 25.8% and there
was a decline in stage IV breast cancers
from 16.8% to 9.4%.
Quality of evidence: Low.
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Campaign

Setting and
Year

Description of Campaign

Campaign Characteristics

Results

Breast Cancer
Promoting Early
Presentation (breast
cancer)

UK, 2007–2008

Linsell et al. 2009.
Forbes et al. 2011.

Rimer et al. 2002.

USA, North
Carolina, 1997–
2000

This was a RCT conducted to compare the
efficacy of two versions of an intervention to
promote early diagnosis of breast cancer. The
intervention was targeted towards older
females who had received free breast cancer
screening as part of the NHS Breast Screening
Programme. The intervention was delivered
during each patient’s final mammogram as part
of the programme and aimed to increase
awareness of breast cancer signs and
symptoms, and encourage females to continue
screening. Participants were randomised to
one of three conditions: (1) usual care (i.e.
recommendation from screening unit
receptionist to have regular mammograms); (2)
the booklet (information on breast cancer signs
and symptoms, and importance of regular
screening); (3) booklet plus interaction with
radiographer—this reinforced messages in the
booklet, with instructions on how to check for
signs and symptoms of breast cancer.

1. Behaviour Change Goal: Breast cancer awareness – measured using
a validated questionnaire asking about knowledge of breast cancer
symptoms, knowledge of risk of breast cancer, and breast checking
behaviour

RCT to assess the effects of a mammography
decision making intervention to increase
knowledge about breast cancer and
mammography, accuracy of breast cancer risk
perceptions, and use of mammography, in
which women aged 40–44 years and 50–54
years enrolled in Blue Cross Shield health
insurance were randomly assigned to one of
three groups: usual care (UC) n=378, tailored
print (TP) materials n=374), or tailored print
materials plus tailored telephone counselling
(TC) n=339.

1. Behaviour Change Goal: Knowledge about breast cancer and
mammography, accuracy of breast cancer risk perceptions, use of
mammography

2. Formative Research: the intervention was developed on the basis of
a pilot trial over a 6 month period
3. Target Groups: females aged 67–70 years, receiving their final
mammogram as part of the NHS Breast Screening Programme
4. Theory: the intervention was based on a theoretical model
developed by Bish et al. (2005) which proposed factors influencing
help seeking behaviour for breast cancer. This includes factors such
as attitudes, intentions, and knowledge of symptoms
5. Communication Strategy: depending on the condition; the most
extensive communication included a face-to-face component with a
radiographer and a booklet provided to each participant, which
included information of breast cancer signs and symptoms, and
recommendations for future breast cancer screening.

2. Formative Research: Baseline telephone interviews were conducted
to inform the tailoring of intervention materials: printed materials
and telephone counselling
3. Target Groups: 1091 women aged 40–44 years and 50–54 years in
North Carolina
4. Theory: Messages and materials were tailored on variables from
the Transtheoretical model (TTM)
5. Communication Strategy: Tailored booklets mailed to participants in
year one containing different messages according to responses
given in baseline survey interview and according to TTM. Second
tailored print intervention mailed following 12 month follow up

Breast, colorectal and prostate cancer interventions with a ‘signs and symptoms’ component

At one and 12 month follow up, patients
in the interaction plus booklet condition
and booklet alone condition were more
breast cancer aware. For example, 33%
and 13% of patients in the interaction
plus booklet and booklet only conditions
were breast cancer aware compared to
4% in the control group.
These effects were sustained at 12
months and 24 months. At 2 years the
PEP intervention increased the
proportion who were breast cancer
aware compared with usual care (21% vs
6% odds ratio 8.1, 95% CI: 2.7–25.0).
Quality of Evidence Rating: High.

At 12 and 24 months, women who
received telephone TP & TC had
significantly greater knowledge and more
accurate breast cancer risk perceptions 2.3 times more likely to answer correctly
than those in UC, and were 40% more
likely to have had mammograms.
Women in TP group had significant
effects for knowledge and accuracy but
were less likely to have had a
mammogram.
Quality of Evidence Rating: High.

Breast, colorectal and prostate cancer interventions with a ‘signs and symptoms’ component

Campaign

Setting and
Year

Description of Campaign

Campaign Characteristics

Results

Breast Cancer
interview was a newsletter designed to reinforce and update the
booklet. Following both waves of print interventions, trained
counsellors called women in the assigned group to discuss
questions and concerns regarding breast cancer and
mammography.
Learn, Share and
Live
Skinner et al. 2000.
Skinner et al. 1998.

USA, St Louis,
Missouri, 1995–
1996.

A community based breast cancer education
programme entitled Learn, Share & Live,
targeted at older urban African American
women implemented through an urban social
service organisation – System to Assure Elderly
Services (STAES).

1. Behaviour Change Goal: Knowledge of breast cancer and
mammography, level of mammography screening
2. Formative Research: Baseline survey conducted with target
population and STAES workers to inform intervention protocol.
3. Target Groups: 323 Older urban African American women, mean
age 73.6 years
4. Theory: Intervention messages were based on the Health Belief
Model and Social Cognitive Theory

From baseline to year 2 mean knowledge
score of breast cancer among
participants increased from 3.4 to 4.1.
The percentage of women adherent to
screening increased from 40% to 68%.
Quality of Evidence Rating: High (quasiexperimental, group randomised
crossover design).

5. Communication Strategy: Steering committee of healthcare &
community experts informed intervention design. Trained STAES
workers delivered educational training in community. Use of peer to
peer networking. Programme brochures and posters.
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Campaign

Setting
and
Year

Description of Campaign

Campaign Characteristics

Results

Colorectal Cancer
Be Clear on
Cancer (bowel
cancer
component)

UK, 2011

Seven week campaign that aimed to increase
the awareness of signs and symptoms of bowel
cancer and encourage people to seek help from
their GP if they have had symptoms for ≥ 3
weeks.

Mayden
Research
2011.

1. Behaviour Change Goal: increased GP visits for signs and symptoms of bowel
cancer
2. Formative Research: The intervention was based on a pilot conducted in one
cancer network in 2010
3. Target Groups: Adults aged over 55 years in lower socio-economic groups and key
influencers such as family and friends
4. Theory: not reported
5. Communication Strategy: the campaign messages, highlighting the symptoms of
blood in stool or looser stool for 3 weeks or more, were disseminated through
posters and TV, radio, and newspaper coverage, as well as live events. Materials
address barriers to presentation such as belief that they might be wasting time or
putting a strain on the health system. Screening kits sent out to people aged 60–69
every two years. Messaging also offered advice on lifestyle behaviour to reduce
cancer risk. Information sessions and training conducted with GPs and pharmacies.

Broadwater
et al. 2004.

US, Utah,
2003

A colon cancer awareness media campaign to
increase public awareness about the importance
of early detection and prevention of colon
cancer aimed at those over 50 years of age.
The campaign message was that there are no
early warning signs of colon cancer, so adults
aged 50 or older are encouraged to contact their
doctor to find the appropriate colon cancer
screening option.

Screen for Life
Jorgenesen et
al. 2001.

US,
National
Campaign,
1999–

Screen for Life is a national multimedia
campaign conducted by the Center for Disease
Control and Prevention, to raise awareness
about colorectal cancer, and encourage men and

1. Behaviour Change Goal: Campaign awareness and recall of messages
2. Formative Research: Market research through telephone interviews to assess
public knowledge, attitudes and behaviour regarding colon cancer. Survey was
informed by pilot testing in 23 randomly selected Utah residents. Focus group
testing of campaign messages was also conducted
3. Target Groups: Adults aged 50 years or over in Utah
4. Theory: Not reported
5. Communication Strategy: TV, radio & print advertising, public relations, celebrity
spokespersons, GP public appearances at road show events, TV broadcasting of a
colonoscopy, grassroots efforts through stakeholders: parent-teacher associations,
business, physicians, health departments.
1. Behaviour Change Goal: Raising awareness of the seriousness of colorectal cancer
and encouraging people to speak to a physician about getting screened for
colorectal cancer

Breast, colorectal and prostate cancer interventions with a ‘signs and symptoms’ component

Evaluation data were available for
74 practices across three cancer
networks in the UK: Mount Vernon,
Anglia and Avon, Somerset and
Wiltshire.
Statistically significant increases in
the public’s unprompted awareness
of blood in poo (27% to 42%) and
looser poo (10% to 23%).
There were significant increases
(48%) in GP attendances for the
three symptoms mentioned in the
campaign.
Quality of Evidence Rating: Low.
409 respondents completed the
colon cancer survey. At baseline
only 36% of survey respondents had
seen or heard advertising about
colon cancer. This increased to 79%
after the campaign. Of the 79% that
had seen or heard an advert, 85%
could recall one of the main
campaign messages.
Quality of Evidence Rating: Low.

No data on knowledge or attitudes.
Process evaluation shows that
Screen for Life PSAs have generated

Breast, colorectal and prostate cancer interventions with a ‘signs and symptoms’ component

Campaign

Setting
and
Year

Description of Campaign

Campaign Characteristics

Results

Colorectal Cancer
CDC, 2012.

ongoing

women aged 50 or older to speak to their GP
about being screened.

2. Formative Research: Extensive review of communication & behavioural science
literature. Key informant interviews, and focus groups with target audiences (74
groups in 30 cities) to explore attitudes and behaviours and test message concepts
and materials
3. Target Groups: Men and women aged 50 years or older, with targeted components
aimed at African Americans, Hispanics, Alaska Natives and Medicare beneficiaries
4. Theory: Formative research process, and campaign messages and materials were
based on Social Cognitive Theory, and the Theory of Planned Behaviour

West of
Scotland
Cancer
Awareness
Project
(WoSCAP)
Eadie and
MacAskill
2002.
Eadie and
MacAskill
2008.
Cancer
Research UK
2007.

UK, West
of
Scotland,
2004–
2005

This was a social marketing campaign aimed to
increase awareness of the signs and symptoms
of bowel cancer and encourage those with
symptoms to present to a GP.

more than 10 billion audience
impressions (number of times seen
or heard by audience members).
A National Health Survey indicated
overall rates of screening for
colorectal cancer among
respondents aged 50 or over
increased from 53.8% to 64.2%
between 2002 and 2008.

5. Communication Strategy: TV public service announcements (PSAs), posters,
brochures, factsheets, radio PSAs, including materials targeted at specific sub
populations (e.g. Hispanics – Spanish language materials). Materials include
information on signs & symptoms: blood in or on your stool, pain aches or cramps
in your stomach that don’t go away, losing weight and you don’t know why.

Quality of Evidence: Low.

1. Behaviour Change Goal: To increase awareness of signs and symptoms of bowel
cancer, and to increase rates of presentation to a GP

Prompted awareness of the
campaign reached 71%, awareness
of coverage of bowel cancer in the
media increased from 39% at
baseline to 68% at follow up.
Awareness of bleeding as a
symptom increased from 62% to
71% and awareness of blood in
motions almost doubled from 15%
to 29%. An approximate 10%
increase in referrals from GPs
occurred due to the campaign.

2. Formative Research: Extensive formative research with the target audience
including focus groups and interviews to identify knowledge, attitudes, behaviours
and barriers. Extensive consultations with professional stakeholders was also
undertaken to identify issues within the healthcare system
3. Target Groups: Males and females aged 40–70 in lower socio-economic groups
4. Theory: the campaign was informed by Social Cognitive Theory, which
conceptualises human behaviour as being the result on individual factors (e.g.
knowledge) and the environment (e.g. social norms, the physical environment)
5. Communication Strategy: TV and radio advertising, posters and literature
(booklets, leaflets), consultation and support of clinicians and nurse specialists,
local implementation teams to facilitate smooth running of the intervention.

In one participating hospital –
Hairmyres – six tumours and 18
polyps were detected and treated
through patients presenting directly
as a result of the campaign.
Quality of Evidence Rating: Low.
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Campaign

Setting
and
Year

Description of Campaign

Campaign Characteristics

Results

Prostate Cancer
Ilic et al. 2007.

Australia,
not
specified

This intervention involved providing educational
materials via video, internet, and pamphlet
about cancer screening (including knowledge of
prostate cancer). The aim was to compare the
three methods of delivery on knowledge,
attitudes, and decision making/screening
intentions for prostate cancer.

1. Behaviour Change Goal: no specific behaviour change goal; the intervention was
targeted towards knowledge and awareness
2. Formative Research: there was no clear evidence for formative research. However,
there was some suggestion that the authors did conduct a literature review to
develop the three methods of delivery
3. Target Groups: males aged 45 years and over who had not been tested for prostate
cancer
4. Theory: not reported

The educational materials led to a
27% increase in knowledge about
prostate cancer (pre and post
comparison).
The magnitude of this increase was
similar between the three methods of
delivery.
Quality of Evidence Rating: Low.

5. Communication Strategy: The educational material was delivered via pamphlet,
video, or internet.
Prostate Man
Lyzun et al.
2008.

Canada,
2007

This is a social marketing campaign aimed at
improving awareness of prostate cancer among
males in North-western Ontario. This campaign
was centred on a fictional comic book character
(‘Prostate Man’), and was intended to use
elements of humour to engage with the target
audience and communicate the campaign
messages. The campaign evolved over a period
of time (2002–2007) and consisted of posters,
cartoons, radio and television advertisements to
raise awareness of prostate cancer signs and
symptoms, as well as the importance of health
behaviours such as visiting a health care
professional, eating healthily, and engaging in
physical activity.

1. Behaviour Change Goal: this campaign has several behaviour change goals. For
example, it aimed to encourage males to visit their healthcare provider regarding
prostate health (including cancer). In addition, the campaign promoted other
health behaviours associated with diet and physical activity
2. Formative Research: the campaign was informed by research indicating the
importance of role models in relation to health seeking behaviours. The campaign
appeared to have been informed by relevant behaviour change principles
(although no specific behaviour change model is referred to)
3. Target Groups: males aged 50 years and over
4. Theory: although some components of behaviour change models were noted, the
campaign did not appear to have been informed by a relevant theory
5. Communication Strategy: The campaign used a variety of communication channels
including posters, cartoons, and advertisements placed on television and radio.

Breast, colorectal and prostate cancer interventions with a ‘signs and symptoms’ component

Data have been reported on the
number of people who visited the
Prostate Man website in 2007; this
included the average amount of time
that people spend on the website.
However, there are no formal
evaluation data examining the effects
of this campaign on awareness of
prostate cancer signs and symptoms,
or on the behaviour change goals.
Quality of Evidence: Very low.

